Terms: = Prostate cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
4 results:
1. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng G; Sundquist J; Sundquist K; Ji J
Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
[TBL] [Abstract] [Full Text] [Related]
3. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent prostate cancer in Patients with Biochemical Recurrence following Radical prostatectomy.
Tanaka T; Kawashima A; Rangel LJ; Schulte PJ; Froemming AT; King BF; Mynderse LA; Karnes RJ
J Urol; 2022 May; 207(5):1038-1047. PubMed ID: 34981952
[TBL] [Abstract] [Full Text] [Related]
4. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract] [Full Text] [Related]
